MICHAEL HAYDEN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

IONIS PHARMACEUTICALS INC

Filing Date Source Excerpt
2019-04-26 Michael Hayden, CM, OBC, MB, ChB, Ph.D., FRCP(C), FRSC, age 67, has served as a Director of Ionis since September 2018. ... Dr. Hayden currently serves on the board of Aurinia Pharmaceuticals and Xenon Pharmaceuticals, publicly held biopharmaceutical companies.
2020-04-24 Director Compensation for Fiscal 2019 Michael Hayden Cash Compensation Earned or Paid ($): $62,500 Stock Awards ($): $460,728 Option Awards ($): $607,645 All Other Compensation ($): $15,246 Total ($): $1,146,299
2021-04-23 Michael Hayden, CM, OBC, MB, ChB, Ph.D., FRCP(C), FRSC, age 69, has served as a Director of Ionis since September 2018. ... Director Compensation for Fiscal 2020 ... Michael Hayden ... Total ($) $805,397.
2022-04-20 Michael Hayden, CM, OBC, MB, ChB, Ph.D., FRCP(C), FRSC, age 70, has served as a Director of Ionis since September 2018. ... Dr. Hayden is also a Killam Professor at the University of British Columbia, the highest honor UBC can confer on any faculty member. ... Dr. Hayden served on the board of Aurinia Pharmaceuticals, Inc. until August 2021, and currently serves on the boards of Xenon Pharmaceuticals, 89Bio, AbCellera Biologics and Oxford Biomedica. ... The Board believes Dr. Hayden is uniquely suited to serve on the Board because he has significant expertise in pharmaceutical research and development, both in academia and in commercial settings. ... Dr. Hayden also serves as the Chair of our Science/Medical Committee. ... The table shows for the fiscal year ended December 31, 2021 certain information with respect to the compensation of our Directors: ... Michael Hayden: Cash Compensation $80,000, Stock Awards $213,587, Option Awards $273,240, Total $581,893.
2024-04-25 Michael Hayden, CM, OBC, MB, ChB, Ph.D., FRCP(C), FRSC, age 72, has served as a Director of Ionis since September 2018. Dr. Hayden is an accomplished scientist and physician and serves as Chair of the Medical and Science Committee. Dr. Hayden received total compensation of $528,038 in 2023.

Data sourced from SEC filings. Last updated: 2025-12-06